Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 18 Apr 2025

Decoding Multiple Myeloma: Single-Cell Insights into Tumor Heterogeneity, Immune Dynamics, and Disease Progression

in Cancer Immunity and Immunotherapy

Zhenzhen Zhao
Zhijie Zhao
Zhiheng Lin
Lu Fan
Xiahou Zhikai
Yujiang Dong
Weiying Bao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1584350

Mini Review

Accepted on 18 Apr 2025

Unraveling the Immunosuppressive Microenvironment of Glioblastoma and Advancements in Treatment

in Cancer Immunity and Immunotherapy

Dongxin Jiang
Yunqian Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1590781

Review

Accepted on 18 Apr 2025

Recent Advances in Biomarkers for Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Jiacheng Zhang
Zehao Song
Yuanjie Zhang
Chentong Zhang
Qi Xue
Guochao Zhang
Fengwei Tan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1554871

Original Research

Accepted on 18 Apr 2025

Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in small cell lung cancer

in Cancer Immunity and Immunotherapy

Xin Wang
Zhenyi Xu
Zhen Lin
Dawei Wu
Yu Tang
Zhihua Pei
Yibo Gao
Jie He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1574434

Original Research

Accepted on 18 Apr 2025

Glypican-3 regulated epithelial mesenchymal transformationrelated genes in osteosarcoma: based on comprehensive tumor microenvironment profiling

in Cancer Immunity and Immunotherapy

Jiaming Zhang
Wei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1566061

Perspective

Accepted on 18 Apr 2025

Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines

in Cancer Immunity and Immunotherapy

Sophie Lund
Chun Gong
Xin Yu
Louis M Staudt
Daniel Hodson
Sebastian Scheich

Frontiers in Immunology

doi 10.3389/fimmu.2025.1589729

Original Research

Accepted on 18 Apr 2025

Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Ziwei Wang
Kunpeng Xu
Han Sun
Jun Liang
Wei Jiang
Luhua Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578057

Original Research

Accepted on 17 Apr 2025

A Lactate-Related tSNE Signature Defines Prognostic Subtypes of Bladder Cancer and Reveals LINC01094-Mediated VIM Stabilization in Metastasis and Drug Resistance Author List and Affiliations

in Cancer Immunity and Immunotherapy

Pu Zhang
Hegan Zhang
Wanli Yu
Dage Fan
Yao Pan
Zhuang Wei
Fangzhen Cai
Qingliu He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1593523

107 views

Case Report

Accepted on 17 Apr 2025

Efficacy of Toripalimab in Combination with Anlotinib in Recurrent Undifferentiated Pleomorphic Sarcoma of the Sinonasal: A Case Report with Biomarker Analysis

in Cancer Immunity and Immunotherapy

Fang Wu
Junqiao Feng
Hong Wang
Shan Wang
Xiaoguang Cui
Ying Liu
Kaihong Ye
Rick Francis Thorne
Xu Dong Zhang
Ting La

Frontiers in Immunology

doi 10.3389/fimmu.2025.1541209

Original Research

Accepted on 17 Apr 2025

Reversing VTN Deficiency Inhibits the Progression of Pancreatic Cancer and Enhances Sensitivity to Anti-PD1 Immunotherapy

in Cancer Immunity and Immunotherapy

Siqi Zhao
Zhaofeng Gao
Lingyu Hu
Yihan Li
Xiaoguang Wang
Xiaoping Li
Minjie Chen
Fei Chen
Zhengwei Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578870

Correction

Accepted on 17 Apr 2025

Corrigendum: Harnessing Single-cell and Multi-omics Insights: STING Pathway-based Predictive Signature for Immunotherapy Response in Lung Adenocarcinoma

in Cancer Immunity and Immunotherapy

Yang Ding
Dingli Wang
Dali Yan
Jun Fan
Zongli Ding
Lei Xue

Frontiers in Immunology

doi 10.3389/fimmu.2025.1613095

Review

Accepted on 17 Apr 2025

Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review

in Cancer Immunity and Immunotherapy

Alberto Sánchez-Camacho
Alberto Torres-Zurita
Laura Gallego-López
Rocío Hernández-Pacheco
Silvia Silva-Romeiro
María del Carmen Álamo de la Gala
Enrique Peral-Gutiérrez de Ceballos
Luis De La Cruz-Merino

Frontiers in Immunology

doi 10.3389/fimmu.2025.1597259

Mini Review

Accepted on 17 Apr 2025

Immunosuppressive Tumor Microenvironment in Pancreatic Cancer: Mechanisms and Therapeutic Targets

in Cancer Immunity and Immunotherapy

Da Pan
Xinyue Li
Xiao Qiao
Qiqi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1582305

101 views

Mini Review

Published on 17 Apr 2025

Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential

in Cancer Immunity and Immunotherapy

Melanie Andrea Jordan
Johannes Morschl
Stella E. Autenrieth

Frontiers in Immunology

doi 10.3389/fimmu.2025.1575509

163 views

Original Research

Published on 17 Apr 2025

The malignant signature gene of cancer-associated fibroblasts serves as a potential prognostic biomarker for colon adenocarcinoma patients

in Cancer Immunity and Immunotherapy

Hao Zhang
Zirui Zhuang
Li Hong
Ruipeng Wang
Jinjing Xu
Youyuan Tang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1589678

187 views

Review

Published on 17 Apr 2025

‘Cell knife’ for cancer: the clinician’s perspective

in Cancer Immunity and Immunotherapy

Zihan Zhou
Yunhao Chen
Yao Wang
Yafang Hong
Hongdan Guan
Fenghao Huang
Fenfang Fu
Xiaobo Li
Rong Zheng
Benhua Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536355

279 views